A Study of Recombinant Vaccinia Virus Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinoma

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Jennerex Biotherapeutics
ClinicalTrials.gov Identifier:
NCT01171651
First received: July 26, 2010
Last updated: January 13, 2014
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2014
  Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)
No publications provided by Jennerex Biotherapeutics

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):